AvePoint (AVPT) Earnings Analysis
AvePoint (AVPT) next reports earnings on 2026-08-06, consensus EPS 0.08 USD. Last quarter (2026-05-07) it beat with EPS 0.1 USD vs 0.08 USD est (+25%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E 55.13.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AVPT next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | 0.08 USD |
| Revenue estimate | 0.12B |
AVPT earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | 0.1 USD | 0.08 USD | +25% | Beat |
| 2026-02-26 | 0.1 USD | 0.09 USD | +11.1% | Beat |
| 2025-11-06 | 0.1 USD | 0.07 USD | +42.9% | Beat |
| 2025-08-07 | 0.06 USD | 0.06 USD | 0% | Beat |
| 2025-02-27 | -0.04 USD | 0.05 USD | -180% | Miss |
| 2024-08-08 | -0.01 USD | -0.00416 USD | -140.4% | Miss |
Beat rate: 4/6 (67%) over reported quarters with consensus data.
AVPT valuation and analyst view
| Trailing P/E | 55.13 |
|---|---|
| Trailing EPS | 0.21855 USD |
| Price / book | 5.82 |
| Dividend yield | 0.00% |
| Market cap | 2.57B |
| Analyst consensus | Buy (9 buy / 3 hold / 0 sell) |
| Avg price target | 13 USD |
Related research pages
Frequently asked questions
When is AvePoint (AVPT)'s next earnings date?
AvePoint is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 0.08 USD and revenue estimate of 0.12B.
Did AVPT beat earnings last quarter?
In its 2026-05-07 report, AVPT posted EPS of 0.1 USD versus a 0.08 USD estimate — a beat of 25%.
What is AVPT's earnings track record?
Over the last 6 reported quarters with consensus data, AVPT beat estimates 4 times (67%).
What is AVPT's current P/E ratio and EPS?
AVPT trades at a trailing P/E of 55.13 on trailing EPS of 0.21854866692299757 USD.
What do analysts rate AVPT?
Analyst consensus is "Buy" across 12 ratings (0 strong buy, 9 buy, 3 hold, 0 sell, 0 strong sell). Average 12-month price target: 13 USD.